Caption Management, LLC Aldeyra Therapeutics, Inc. Put Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2024 Feb 14, 2025	BUY	$4.21 - $5.9 $1.68 Million - $2.36 Million	399,600 New	399,600 $1.99 Million
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $461,700 - $921,499	-190,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.25 - $5.17 $167,050 - $265,738	51,400 Added 37.09%	190,000 $846,000
Q4 2021 Feb 11, 2022	BUY	$3.5 - $9.63 $88,200 - $242,676	25,200 Added 22.22%	138,600 $555,000
Q3 2021 Nov 12, 2021	BUY	$7.94 - $11.31 $900,396 - $1.28 Million	113,400 New	113,400 $996,000

130

38M

764K

544K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $379M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.